Results
13
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RAA | €863.50 | -2.9% | 41.2% | €9.8b | €777.19 | PE41.6x | E6.9% | 0.01% | Capital Goods | ||
EVD | €89.70 | -0.6% | 42.8% | €8.6b | €97.27 | PE27.2x | E5.6% | 1.6% | Media | ||
MUM | €52.70 | -0.4% | 5.0% | €895.5m | €71.00 | PE28x | E14.0% | 3.1% | Software | ||
HG1 | €38.20 | 1.1% | -1.5% | €596.1m | n/a | PE11.9x | n/a | 2.6% | Capital Goods | ||
WSU | €38.00 | -4.3% | 11.8% | €508.5m | €49.13 | PE17.9x | E14.3% | 5.8% | Capital Goods | ||
ETG | €31.80 | 4.6% | -19.5% | €472.2m | n/a | PE9.5x | n/a | 9.4% | Energy | ||
PM1 | €5.90 | 0% | 10.1% | €258.8m | n/a | PE3.1x | n/a | 10.7% | Transportation | ||
93M1 | €24.20 | 4.3% | 58.2% | €106.2m | €108.00 | PE0.9x | E-65.7% | 5.0% | Pharmaceuticals & Biotech | ||
M3V | €24.80 | 2.5% | -6.8% | €45.1m | n/a | PE7.8x | n/a | 3.8% | Healthcare | ||
FPH | €2.20 | 0.9% | -28.1% | €34.4m | €5.10 | PE2.8x | E-40.7% | 0% | Commercial Services | ||
ETE | €8.20 | 0% | -55.4% | €25.7m | n/a | PE0.9x | n/a | 0.4% | Capital Goods | ||
T3T1 | €5.65 | -3.4% | 1.8% | €21.3m | n/a | PE10.3x | n/a | n/a | Software | ||
OJ2 | €2.30 | -4.2% | -10.9% | €2.3m | n/a | PE1.7x | n/a | n/a | Commercial Services |